Caliper Life Sciences, a Hopkinton, MA-based provider of life sciences research products and services, said today that it has sold its small animal services business, Xenogen Biosciences (XenBio), to the laboratory rodent provider Taconic Farms for about $11 million. Taconic, headquartered in Hudson, NY, is also becoming the distributor of Caliper’s transgenic rodents that can indicate gene activation and drug responses with florescent light. Caliper (NASDAQ:[[ticker:CALP]]) acquired the XenBio business through its 2006 buyout of Xenogen.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
